Cassava Sciences (NASDAQ: SAVA) furnishes operations and financial update

Rhea-AI Filing Summary

Cassava Sciences, Inc. filed a current report to note that it released a press release on November 12, 2025 covering its results of operations and financial condition. The company attached this press release as Exhibit 99.1 and stated that the information is being furnished, not filed, which limits how it is treated under securities law. The filing also identifies Cassava’s common stock, par value $0.001, as trading under the symbol SAVA on the NASDAQ Capital Market.

8-K Event Classification

2 items: 2.02, 9.01

2 items

Item 2.02 Results of Operations and Financial Condition Financial

Disclosure of earnings results, typically an earnings press release or preliminary financials.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Understanding 8-K Material Events →

False000106953000010695302025-11-122025-11-12iso4217:USDxbrli:sharesiso4217:USDxbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________________

FORM 8-K

_________________

CURRENT REPORT

Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  November 12, 2025

_______________________________

Cassava Sciences, Inc.

(Exact name of registrant as specified in its charter)

_______________________________

Delaware	001-41905	91-1911336
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)

6801 N Capital of Texas Highway, Building 1; Suite 300

Austin, Texas 78731

(Address of Principal Executive Offices) (Zip Code)

(512) 501-2444

(Registrant's telephone number, including area code)

(Former name or former address, if changed since last report)

_______________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.001 par value	SAVA	NASDAQ Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02. Results of Operations and Financial Condition.

On November 12, 2025, the Registrant issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

The information provided in this Current Report, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section. Such information shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any incorporation by reference language in such filing.

Item 9.01. Financial Statements and Exhibits.

Exhibit Number		Description
99.1		Press Release dated November 12, 2025
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Cassava Sciences, Inc.
	a Delaware corporation
Date: November 12, 2025	By:	/s/ Eric J. Schoen
		Eric J. Schoen
		Chief Financial Officer

FAQ

What did Cassava Sciences (SAVA) report in this 8-K filing?

Cassava Sciences reported that it issued a press release on November 12, 2025 describing its results of operations and financial condition, which is attached as Exhibit 99.1.

How is the information in Cassava Sciences’ November 12, 2025 8-K treated?

Cassava Sciences stated that the information in this report, including Exhibit 99.1, is being furnished and not deemed filed under the Securities Exchange Act of 1934.

What exhibit is included with Cassava Sciences’ November 12, 2025 8-K?

The filing includes Exhibit 99.1, a press release dated November 12, 2025, and Exhibit 104, the cover page interactive data file embedded within the Inline XBRL document.

On which exchange is Cassava Sciences (SAVA) common stock listed?

Cassava Sciences’ common stock, $0.001 par value, is listed on the NASDAQ Capital Market under the trading symbol SAVA.

Who signed Cassava Sciences’ November 12, 2025 8-K?

The report was signed on behalf of Cassava Sciences, Inc. by Eric J. Schoen, the company’s Chief Financial Officer.